SCHEMBL179467

SCHEMBL179467

COc1ccc(C(C)(C)C)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.50
CA1 P00915 2/20 0.50
CA9 Q16790 2/20 0.50
ACHE P22303 1/20 0.50
CA12 O43570 1/20 0.50
CA7 P43166 1/20 0.50
CA14 Q9ULX7 1/20 0.50
HSD17B10 Q99714 2/20 0.47
CASP1 P29466 1/20 0.47
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TRPV1 Q8NER1 1/20 0.45
TSHR P16473 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29436012 1.00 CA2 (0.50) CA2CA1CA9ACHECA12
SCHEMBL28891675 0.92 CA2 (0.44) CA2CA1CA9ACHECA12
SCHEMBL15372163 0.87 CA1 (0.44) CA2CA1CA9HSD17B10ALDH1A1
SCHEMBL18537068 0.86 CA2 (0.46) CA2CA1CA9ACHECA12
SCHEMBL1542268 0.86 CA1 (0.43) CA2CA1CA9ACHECA12
SCHEMBL12024903 0.84 KDM4E (0.56) HSD17B10ALDH1A1SMN1; SMN2TSHRPOLB
SCHEMBL13698781 0.84 CA1 (0.42) CA2CA1CA9HSD17B10CASP1
SCHEMBL7849070 0.84 KMT2A (0.43) CA2CA1CA9HSD17B10CASP1
SCHEMBL12828080 0.84 CA1 (0.42) CA2CA1CA9HSD17B10CASP1
SCHEMBL12024915 0.84 PDE4A (0.47) HSD17B10ALDH1A1SMN1; SMN2TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116973774-A Method for measuring self-discharge of battery, redox electrolyte and application 上海瑞浦青创新能源有限公司 2023-10-31 CN claimed
US-20230187709-A1 Safe Lithium-Ion Battery and Manufacturing Method Therefor SHANGHAI RUIPU ENERGY CO., LTD. (CN) 2023-06-15 US claimed
EP-4156363-A1 SAFE LITHIUM-ION BATTERY AND MANUFACTURING METHOD THEREFOR REPT BATTERO Energy Co., Ltd. (CN) 2023-03-29 EP claimed
CN-114914536-A Electrolyte for lithium battery, and method for improving performance of high-temperature lithium battery 中国科学院物理研究所 2022-08-16 CN claimed
CN-113054253-B Overcharge-proof electrolyte of lithium ion battery 江西格林德能源有限公司 2022-08-12 CN claimed
CN-114883677-A Lithium pre-preparing method for lithium ion battery 上海瑞浦青创新能源有限公司 2022-08-09 CN claimed
WO-2022161070-A1 SAFE LITHIUM-ION BATTERY AND MANUFACTURING METHOD THEREFOR 瑞浦兰钧能源股份有限公司 2022-08-04 WO claimed
CN-114171782-A Overcharge-resistant sodium ion battery electrolyte and preparation method thereof 河南省法恩莱特新能源科技有限公司 2022-03-11 CN claimed
CN-113054253-A Overcharge-proof electrolyte of lithium ion battery 江西格林德能源有限公司 2021-06-29 CN claimed
CN-112467193-A Safety lithium ion battery and preparation method thereof 上海瑞浦青创新能源有限公司 2021-03-09 CN claimed
CN-111710838-A Preparation method and application of modified sodium-ion battery positive electrode material 溧阳中科海钠科技有限责任公司 2020-09-25 CN claimed
US-20160056418-A1 LI-ION MONOBLOCK BATTERY FOR STOP/START APPLICATIONS FORD GLOBAL TECHNOLOGIES, LLC 2016-02-25 US claimed
EP-1733450-B1 REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL 3M INNOVATIVE PROPERTIES CO (US) 2010-12-08 EP claimed
US-7811710-B2 Redox shuttle for rechargeable lithium-ion cell 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-10-12 US claimed
EP-1733450-A2 REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL 3M Innovative Properties Company (US) 2006-12-20 EP claimed
WO-2005099024-A2 REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-10-20 WO claimed
US-20050221196-A1 Redox shuttle for rechargeable lithium-ion cell 3M INNOVATIVE PROPERTIES COMPANY 2005-10-06 US claimed
EP-4636890-A2 ELECTROLYTE COMPOSITIONS Faradion Limited (GB) 2025-10-22 EP disclosed
US-20040082578-A1 Arylindenopyridines and related therapeutic and prophylactic methods ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-04-29 US disclosed
WO-2003024448-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082578-A1 Arylindenopyridines and related therapeutic and prophylactic methods ADORA2A, ADORA1, PDE2A CA2 1193/4885CA1 2705/4885CA9 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.